Training Doyens

With the evolution of the pharmaceutical industry, the advent of digital tools, processes, and platforms has also been prominent. This has dramatically transformed the face of clinical trials and is making way for new opportunities to improve the trial processes further. However, in this changing scenario, the professionals need to develop new systems and procedures to evaluate new technologies and analyze if these can streamline the trail experiences. On a global scale, the expenditure of Pharma companies on R&D is more than USD 140 billion. Over the past decade, the clinical trial costs have increased greatly and there is more than 150 percent increase in the average cost per patient. And, the highest cost in a clinical trial can be attributed to patient recruitment cost, which has more than 30% of share. A major contributing factor in this is a late-phase clinical trial where patient engagement and retention is an issue that must be handled carefully for the success of the...